Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela White

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Regulatory Toxicology and Pharmacology : RTP|August 18, 2018
Managing emerging mutagenicity risks: Late stage mutagenic impurity control within the atovaquone second generation synthesisMichael W J Urquhart, Ben Bardsley, Andrew J Edwards, et al.
Journal of Applied Toxicology : JAT|March 1, 2017
A quantitative in silico model for predicting skin sensitization using a nearest neighbours approach within expert-derived structure-activity alert spacesSteven J Canipa, Martyn L Chilton, Rachel Hemingway, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Discovery of a First-in-Class Gut-Restricted RET Kinase Inhibitor as a Clinical Candidate for the Treatment of IBSHilary Schenck Eidam, John Russell, Kaushik Raha, et al.
American Journal of Human Genetics|December 1, 2009
A cytogenetic abnormality and rare coding variants identify ABCA13 as a candidate gene in schizophrenia, bipolar disorder, and depressionHelen M Knight, Benjamin S Pickard, Alan Maclean, et al.
Journal of Child Neurology|September 3, 2020
Practical Approaches and Knowledge Gaps in the Care for Children With LeukodystrophiesStephanie R Keller, Eric J Mallack, Jennifer P Rubin, et al.
Regulatory Toxicology and Pharmacology : RTP|February 17, 2016
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicityErnst Ahlberg, Alexander Amberg, Lisa D Beilke, et al.
Regulatory Toxicology and Pharmacology : RTP|February 16, 2016
Principles and procedures for implementation of ICH M7 recommended (Q)SAR analysesAlexander Amberg, Lisa Beilke, Joel Bercu, et al.
Frontiers in Neurology|July 8, 2024
The global patient-reported outcomes for multiple sclerosis initiative: bridging the gap between clinical research and care - updates at the 2023 plenary eventPaola Zaratin, Sara Samadzadeh, Meral Seferoğlu, et al.
Regulatory Toxicology and Pharmacology : RTP|December 19, 2018
Principles and procedures for handling out-of-domain and indeterminate results as part of ICH M7 recommended (Q)SAR analysesAlexander Amberg, Roxanne V Andaya, Lennart T Anger, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Regulatory Toxicology and Pharmacology : RTP|August 18, 2018
Managing emerging mutagenicity risks: Late stage mutagenic impurity control within the atovaquone second generation synthesisMichael W J Urquhart, Ben Bardsley, Andrew J Edwards, et al.
Journal of Applied Toxicology : JAT|March 1, 2017
A quantitative in silico model for predicting skin sensitization using a nearest neighbours approach within expert-derived structure-activity alert spacesSteven J Canipa, Martyn L Chilton, Rachel Hemingway, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Discovery of a First-in-Class Gut-Restricted RET Kinase Inhibitor as a Clinical Candidate for the Treatment of IBSHilary Schenck Eidam, John Russell, Kaushik Raha, et al.
American Journal of Human Genetics|December 1, 2009
A cytogenetic abnormality and rare coding variants identify ABCA13 as a candidate gene in schizophrenia, bipolar disorder, and depressionHelen M Knight, Benjamin S Pickard, Alan Maclean, et al.
Journal of Child Neurology|September 3, 2020
Practical Approaches and Knowledge Gaps in the Care for Children With LeukodystrophiesStephanie R Keller, Eric J Mallack, Jennifer P Rubin, et al.
Regulatory Toxicology and Pharmacology : RTP|February 17, 2016
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicityErnst Ahlberg, Alexander Amberg, Lisa D Beilke, et al.
Regulatory Toxicology and Pharmacology : RTP|February 16, 2016
Principles and procedures for implementation of ICH M7 recommended (Q)SAR analysesAlexander Amberg, Lisa Beilke, Joel Bercu, et al.
Frontiers in Neurology|July 8, 2024
The global patient-reported outcomes for multiple sclerosis initiative: bridging the gap between clinical research and care - updates at the 2023 plenary eventPaola Zaratin, Sara Samadzadeh, Meral Seferoğlu, et al.
Regulatory Toxicology and Pharmacology : RTP|December 19, 2018
Principles and procedures for handling out-of-domain and indeterminate results as part of ICH M7 recommended (Q)SAR analysesAlexander Amberg, Roxanne V Andaya, Lennart T Anger, et al.
Pageof 6